These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 23012989)

  • 1. [Peripheral mechanisms of action of oxatriazolium-5-olate derivative 3-(3-[1,2,4]-triazolo)oxatriazolium-5-olate in spontaneously hypertensive rats].
    Artem'eva MM; Postnikov AB; Akinfieva OV; Daliger IL; Shevelev SA; Medvedev OS; Medvedeva NA
    Eksp Klin Farmakol; 2012; 75(8):11-4. PubMed ID: 23012989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries.
    Persson AA; Gunnarsson P; Lindström E; Grenegård M
    Eur J Pharmacol; 2005 Oct; 521(1-3):124-32. PubMed ID: 16182278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
    Fernandes D; da Silva-Santos JE; Duma D; Villela CG; Barja-Fidalgo C; Assreuy J
    Mol Pharmacol; 2006 Mar; 69(3):983-90. PubMed ID: 16326931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
    Tseng CM; Tabrizi-Fard MA; Fung HL
    J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypotensive effect of oxatriazolo-5-olate derivative in chronic experiments on SHR rats].
    Artem'eva MM; Postnikov AB; Akinfieva OV; Daliger IL; Shevelev SA; Medvedev OS; Medvedeva NA
    Eksp Klin Farmakol; 2009; 72(3):13-5. PubMed ID: 19642586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypotensive effect of oxatriazolium-5-olate derivative].
    Artem'eva MM; Postnikov AB; Akinfrieva OV; Daliger IL; Shevelev SA; Medvedev OS; Medvedeva NA
    Eksp Klin Farmakol; 2008; 71(5):25-7. PubMed ID: 19093367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme.
    Pankey EA; Bhartiya M; Badejo AM; Haider U; Stasch JP; Murthy SN; Nossaman BD; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H792-802. PubMed ID: 21217076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
    Schrammel A; Behrends S; Schmidt K; Koesling D; Mayer B
    Mol Pharmacol; 1996 Jul; 50(1):1-5. PubMed ID: 8700100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
    Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
    Priviero FB; Teixeira CE; Toque HA; Claudino MA; Webb RC; De Nucci G; Zanesco A; Antunes E
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):448-55. PubMed ID: 16700877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries.
    Irvine JC; Favaloro JL; Kemp-Harper BK
    Hypertension; 2003 Jun; 41(6):1301-7. PubMed ID: 12743008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation.
    Faraci FM; Sobey CG
    Brain Res; 1999 Mar; 821(2):368-73. PubMed ID: 10064823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
    Hwang TL; Wu CC; Teng CM
    Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine-induced vasodilation involves voltage-gated potassium channels in rat aorta.
    Han WQ; Zhu DL; Wu LY; Chen QZ; Guo SJ; Gao PJ
    Life Sci; 2009 May; 84(21-22):732-7. PubMed ID: 19268479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursolic acid mediates the vasorelaxant activity of Lepechinia caulescens via NO release in isolated rat thoracic aorta.
    Aguirre-Crespo F; Vergara-Galicia J; Villalobos-Molina R; Javier López-Guerrero J; Navarrete-Vázquez G; Estrada-Soto S
    Life Sci; 2006 Aug; 79(11):1062-8. PubMed ID: 16630635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation.
    Jones AW; Durante W; Korthuis RJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):85-91. PubMed ID: 20605906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
    Garthwaite J; Southam E; Boulton CL; Nielsen EB; Schmidt K; Mayer B
    Mol Pharmacol; 1995 Aug; 48(2):184-8. PubMed ID: 7544433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Aryl- and 2-amido-benzothiazoles as multifunctional vasodilators on rat artery preparations.
    Fusi F; Durante M; Sgaragli G; Cuong NM; Dung PT; Nam NH
    Eur J Pharmacol; 2013 Aug; 714(1-3):178-87. PubMed ID: 23751511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-hydroxytryptamine- and U46619-mediated vasoconstriction in bovine pulmonary conventional and supernumerary arteries: effect of endogenous nitric oxide.
    Bunton D; MacDonald A; Brown T; Tracey A; McGrath JC; Shaw AM
    Clin Sci (Lond); 2000 Jan; 98(1):81-9. PubMed ID: 10600662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxynitrite has potent pulmonary vasodilator activity in the rat.
    Casey DB; Pankey EA; Badejo AM; Bueno FR; Bhartiya M; Murthy SN; Uppu RM; Nossaman BD; Kadowitz PJ
    Can J Physiol Pharmacol; 2012 Apr; 90(4):485-500. PubMed ID: 22452357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.